K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: A population-based study in China

Clinical Cancer Research

Volumn 8, Issue 10, 2002, Pages 3156-3163

  Rashid, Asif ^a,b   Ueki, Takashi ^a   Gao, Yu Tang ^c   Houlihan, Patrick Scott ^b   Wallace, Charita ^b   Wang, Bing Sheng ^d   Shen, Ming Chang ^e   Deng, Jie ^c   Hsing, Ann W ^f  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c SHANGHAI CANCER INSTITUTE   (China)

^d ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^e FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BILIARY TRACT CANCER; CHINA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MUCINOUS CARCINOMA; ONCOGENE K RAS; ONSET AGE; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; TUMOR LOCALIZATION;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; BILIARY TRACT NEOPLASMS; CARCINOMA, PAPILLARY; CHINA; DNA, NEOPLASM; FEMALE; GENES, P53; GENES, RAS; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SURVIVAL RATE;

EID: 0036793788     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Fraumeni, J. F., Jr., Devesa, S. S., McLaughlin, J. K., and Stanford, J. L. Biliary tract cancer. In: D. Schottenfeld and J. F. Fraumeni, Jr. (eds), Cancer Epidemiology and Prevention, Ed. 2, pp. 794-805. New York: Oxford University Press, 1996.
2. Hsing, A. W., Gao, Y-T., Devesa, S. S., Jin, F., and Fraumeni, J. F., Jr. Rising incidence of biliary tract cancers in Shanghai. China Int. J. Cancer, 75: 368-370, 1998.
3. Tada, M., Yokosuka, O., Omata, M., Ohto, M., and Isono, K. Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing. Cancer (Phila.), 66: 930-935, 1990.
4. Levi, S., Urbano-Ispizua, A., Gill, R., Thomas, D. M., Gilbertson, J., Foster, C., and Marshall, C. J. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res., 51: 3497-3502, 1991.
5. Motojima, K., Tsunoda, T., Kanematsu, T., Nagata, Y., Urano, T., and Shiku, H. Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten-ras oncogene. Ann. Surg., 214: 657-662, 1991.
6. Scarpa, A., Capelli, P., Zamboni, G., Oda, T., Mukai, K., Bonetti, F., Martignoni, G., Iacono, C., Serio, G., and Hirohashi, S. Neoplasia of the ampulla of Vater: Ki-ras and p53 mutations. Am. J. Pathol., 142: 1163-1172, 1993.
7. Imai, M., Hoshi, T., and Ogawa, K. K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis. Cancer (Phila.), 73: 2727-2733, 1994.
8. Wistuba, I. I., Sugio, K., Hung, J., Kishimoto, Y., Virmani, A. K., Rao, I., Albores-Saavedra, J., and Gazdar, A. F. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res., 55: 2511-2515, 1995.
9. Malats, N., Porta, M., Pinol, J. L., Corominas, J. M., Rifa, J., and Real, F. X. Ki-ras mutations as a prognostic factor in extrahepatic bile system cancer. J. Clin. Oncol., 13: 1679-1686, 1995.
10. Chung, C. H., Wilentz, R. E., Polak, M. M., Ramsoekh, T. B., Noorduyn, L. A., Gouma, D. J., Huibregtse, K., Offerhaus, G. J. A., and Slebos, R. J. C. Clinical significance of K-ras oncogene activation in ampullary neoplasms. J. Clin. Pathol., 49: 460-464, 1996.
11. Howe, J. R., Klimstra, D. S., Cordon-Cardo, C., Paty, P. B., Park, P. Y., and Brennan, M. F. K-ras mutation in adenomas and carcinomas of the ampulla of Vater. Clin. Cancer Res., 3: 129-133, 1997.
12. Rijken, A. M., van Gulik, T. M., Polak, M. M., Sturm, P. D. J., Gouma, D. J., and Offerhaus, G. J. A. Diagnostic and prognostic value of incidence of K-ras codon 12 mutations in resected distal bile duct carcinoma. J. Surg. Oncol., 68: 187-192, 1998.
13. Suto, T., Habano, W., Sugai, T., Uesugi, N., Funato, O., Kanno, S., Saito, K., and Nakamura, S. Aberrations of the K-ras, p53, and APC genes in extrahepatic bile duct cancer. J. Surg. Oncol., 73: 158-163, 2000.
14. Ink4B/MTS2 genes in biliary tract cancers. Cancer Res., 55: 2756-2760, 1995.
15. Imai, Y., Oda, H., Tsurutani, N., Nakatsuru, Y., Inoue, T., and Ishikawa, T. Frequent somatic mutations of the APC and p53 genes in sporadic ampullary carcinomas. Jpn. J. Cancer Res., 88: 846-854, 1997.
16. Rashid, A., Gao, Y-T., Bhakta, S., Shen, M-C., Wang, B-S., Deng, J., Fraumeni, J. F., Jr., and Hsing, A. W. β-Catenin mutations in biliary tract cancers: a population-based study in China. Cancer Res., 61: 3406-3409, 2001.
17. Hanada, K., Itoh, M., Fujii, K., Tsuchida, A., Hirata, M., Iwao, T., Eguchi, N., Sasaki, T., Matsubara, K., and Kajiyama, G. TP53 mutations in stage I gallbladder carcinoma with special attention to growth patterns. Eur. J. Cancer, 33: 1136-1140, 1997.
18. Jonas, S., Springmeier, G., Tauber, R., Wiedenmann, B., Lobeck, H., Gessner, R., Kreft, B., Kling, N., Moelling, K., and Neuhaus, P. p53 mutagenesis in Klatskin tumors. Hum. Pathol., 29: 955-960, 1998.
19. Diamantis, I., Karamitopoulou, E., Perentes, E., and Zimmerman, A. p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival. Hepatology, 22: 774-779, 1995.
20. Younes, M., Riley, S., Genta, R. M., Mosharaf, M., and Mody, D. R. p53 protein accumulation in tumors of the ampulla of Vater. Cancer (Phila.), 76: 1150-1154, 1995.
21. Wistuba, I. I., Gazdar, A. F., Roa, I., and Albores-Saavedra, J. p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. Hum. Pathol., 27: 360-365, 1996.
22. Washington, K., and Gottfried, M. R. Expression of p53 in adenocarcinoma of the gallbladder and bile ducts. Liver, 16: 99-104, 1996.
23. Hidaka, E., Yanagisawa, A., Sakai, Y., Seki, M., Kitagawa, T., Setoguchi, T., and Kato, Y. Losses of heterozygosity on chromosome 17p and 9p/18q may play important roles in early and advanced phases of gallbladder carcinogenesis. J. Cancer Res. Clin. Oncol., 125: 439-443, 1995.
24. Ding, S-F., Delhanty, J. D. A., Bowles, L., Dooley, J. S., Wood, C. B., and Habib, N. A. Loss of constitutional heterozygosity on chromosomes 5 and 17 in cholangiocarcinoma. Br. J. Cancer, 67: 1007-1010, 1993.
25. Wistuba, I. I., Tang, M., Maitra, A., Alvarez, H., Troncoso, P., Pimentel, F., and Gazdar, A. F. Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma. Cancer Res., 61: 3795-3800, 2001.
26. Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodriguez-Bigas, M. A., Fodde, R., Ranzani, G. N., and Srivastava, S. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res., 58: 5248-5257, 1998.
27. Ionov, Y., Peinado, M., Malkhosyan, S., Shibata, D., and Perucho, M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature (Lond.), 363: 558-561, 1993.
28. Kim, H., Jen, J., Vogelstein, B., and Hamilton, S. R. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am. J. Pathol., 145: 148-156, 1994.
29. Kolodner, R. D., and Marsischky, G. T. Eukaryotic DNA mismatch repair. Curr. Opin. Genet. Dev., 9: 89-96, 1999.
30. Boland, C. R. Roles of the DNA mismatch repair genes in colorectal tumorigenesis. Int. J. Cancer, 69: 47-49, 1996.
31. Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., and Lindblom, A. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature (Lond.), 368: 258-261, 1994.
32. Fishel, R., Lescoe, M. K., Rao, M. R., Copeland, N. G., Jenkins, N. A., Garber, J., Kane, M., and Kolodner, R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell, 75: 1027-1038, 1993.
33. Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R., Peltomaki, P., Sistonen, P., Aaltonen, L. A., and Nystrom-Lahti, M. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell, 75: 1215-1225, 1993.
34. Liu, B., Parsons, R., Papadopoulos, N., Nicolaides, N. C., Lynch, H. T., Watson, P., Jass, J. R., Dunlop, M., Wyllie, A., Peltomaki, P., de la Chapelle, A., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat. Med., 2: 169-174, 1996.
35. Grady, W., Myerhoff, L., Swinler, S., Rajput, A., Thiagalingam, S., Lutterbaugh, J. D., Neumann, A., Brattain, M. G., Chang, J., Kim, S. J., Kinzler, K. W., Vogelstein, B., Willson, J. K., and Markowitz, S. Mutational inactivation of transforming growth factor β receptor type II in microsatellite stable colon cancers. Cancer Res., 59: 320-324, 1999.
36. Myeroff, L. L., Parsons, R., Kim, S-J., Hedrick, L., Cho, K. R., Orth, K., Mathis, M., Kinzler, K. W., Lutterbaugh, J., and Park, K. A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res., 55: 5545-5547, 1995.
37. Togo, G., Toda, N., Kanai, F., Kato, N., Shiratori, Y., Kishi, K., Imazeki, F., Makuuchi, M., and Omata, M. A transforming growth factor β type II receptor gene mutation common in sporadic cecum cancer with microsatellite instability. Cancer Res., 56: 5620-5623, 1996.
38. Tomita, S., Muto, Y., Kusano, T., and Toda, T. Genetic alterations in human malignant tumor. Rinsho Byori, 47: 20-26, 1999.
39. Suto, T., Habano, W., Sugai, T., Uesugi, T., Kanno, S., Saito, K., and Nakamura, S. Infrequent microsatellite instability in biliary tract cancers. J. Surg. Oncol., 76: 121-126, 2001.
40. Albores-Saavedra, J., Henson, D. E., and Sobin, L. H. In: J. Albores-Saavedra, D. E. Henson, and L. H. Sobin (eds.), WHO Histological Typing of Tumors of the Gallbladder and Extrahepatic Bile Ducts, pp. 1-75. Berlin: Springer-Verlag, 1991.
41. Moskaluk, C. A., and Kern, S. E. Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. Am. J. Pathol., 150: 1547-1552, 1997.
42. Redston, M. S., Caldas, C., Seymour, A. B., Hruban, R. H., da Costa, L., Yeo, C. J., and Kern, S. E. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res., 54: 3025-3033, 1994.
43. Baas, I. O., Mulder, J-W. R., Offerhaus, G. J. A., Vogelstein, B., and Hamilton, S. R. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J. Pathol., 172: 5-12, 1994.
44. Parsons, R., Myeroff, L. L., Liu, B., Willson, J. K., Markowitz, S. D., Kinzler, K. W., and Vogelstein, B. Microsatellite instability and mutations of the transforming growth factor β type H receptor gene in colorectal cancer. Cancer Res., 55: 5548-5550, 1995.
45. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
46. Kiba, T., Tsuda, H., Pairojkul, C., Inoue, S., Sugimura, T., and Hirohashi, S. Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand. Mol. Carcinog., 8: 312-318, 1993.
47. Wistuba, I. I., and Albores-Saavedra, J. Genetic abnormalities involved in the pathogenesis of gallbladder carcinoma. J. Hepatobiliary Pancreat. Surg., 6: 237-244, 1999.
48. Wistuba, I. I., Miquel, J. F., Gazdar, A. F., and Albores-Saavedra, J. Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas. Hum. Pathol., 30: 21-25, 1999.
49. Hanada, K., Itoh, M., Fujii, K., Tsuchida, A., Ooishi, H., and Kajiyama, G. K-ras and p53 mutations in stage I gallbladder carcinoma with an anomolous junction of the pancreaticobiliary duct. Cancer (Phila.), 77: 452-458, 1996.
50. Hidaka, E., Yanagisawa, A., Seki, M., Takano, K., Setoguchi, T., and Kato, Y. High frequency of K-ras mutations in biliary tract carcinomas of cases with a long common channel in the papilla of Vater. Cancer Res., 60: 522-524, 2000.
51. Ohashi, K., Tsutsumi, M., Nakajima, Y., Noguchi, O., Okita, S., Kitada, H., Tsujiunchi, T., Kobayashi, E., Nakano, H., and Konishi, Y. High rates of Ki-ras point mutation in both intra- and extra-hepatic cholangiocarcinomas. Jpn. J. Clin. Oncol., 24: 305-310, 1994.
52. Suto, T., Sugai, T., Nakamura, S., Funato, O., Nitta, H., Sasaki, R., Kanno, S., and Saito, K. Assessment of the expression of p53, MIB-1 (Ki-67 antigen) and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct. Cancer (Phila.), 82: 86-95, 1998.
53. Ruschoff, J., Dietmaier, W., Luttges, J., Seitz, G., Bocker, T., Zirngibi, H., Schlegel, J., Schackert, H. K., Jauch, K. W., and Hofstaedter, F. Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics. Am. J. Pathol., 150: 1815-1825, 1997.
54. Jass, J. R., Do, K-A., Simms, L. A., Iino, H., Wynter, C., Pillay, S. P., Searle, J., Radford-Smith, G., Young, J., and Leggett, B. Morphology of sporadic colorectal cancer with DNA replication errors. Gut, 42: 673-679, 1998.
55. +. Am. J. Pathol., 152: 1501-1507, 1998.
56. Wilentz, R. E., Goggins, M., Redston, M., Marcus, V. A., Adsay, N. V., Sohn, T. A., Kadkol, S. S., Yeo, C. J., Choti. M., Zahurak, M., Johnson, K., Tascilar, M., Offerhaus, G. J. A., Hruban, R. H., and Kern, S. E. Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: a newly described and characterized entity. Am. J. Pathol., 156: 1641-1651, 2000.
57. Gryfe, R., Kim, H., Hsieh, E. T. K., Aronson, M. D., Holowaty, E. J., Bull, S. B., Redston, M., and Gallinger, S. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N. Engl. J. Med., 342: 69-77, 2000.